Jan Orwar

Direktor/Vorstandsmitglied bei FLUICELL AB

62 Jahre

Consumer Services

Commercial Services

Health Technology

Profil

Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.

Aktive Positionen von Jan Orwar

Unternehmen	Position	Beginn
FLUICELL AB	Direktor/Vorstandsmitglied	01.01.2015
Chalmers University of Technology Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	17.01.2011
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Alle aktiven Positionen von Jan Orwar

Ehemalige bekannte Positionen von Jan Orwar

Unternehmen	Position	Ende
Nanoxis AB Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research	Gründer	11.02.2014
PIRML ENT	Technik-/Wissenschafts-/F&E-Leiter	-
Sanofi AB Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment	Technik-/Wissenschafts-/F&E-Leiter	-
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Vorstandsvorsitzender	-
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Gründer	-

Sehen Sie sich die Erfahrung von Jan Orwar im Detail an

Ausbildung von Jan Orwar

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jan Orwar im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	10
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Commercial Services
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Piramal Enterprises Ltd. Piramal Enterprises Ltd. Investment ManagersFinance Provides asset management, loan and housing finance services and manufactures pharmaceuticals	Finance
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Chalmers University of Technology Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Gothenburg University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nanoxis AB Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research	Commercial Services
Fluicell AB Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research	Health Technology
Sanofi AB Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment	Distribution Services
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Health Technology